NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · Real-Time Price · USD

13.22

-0.16 (-1.20%)

Mar 24, 2026, 11:50 AM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products	99.99M	79.91M	65.42M	45.52M	45.18M
Medical Products Growth	25.13%	22.14%	43.72%	0.75%	9.83%
Total	99.99M	79.91M	65.42M	45.52M	45.18M
Total Growth	25.13%	22.14%	43.72%	0.75%	9.83%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	99.09M	79.71M	-	45.52M	45.18M
United States Growth	24.31%	-	-	0.75%	9.83%
Foreign	900.00K	200.00K	-	-	-
Foreign Growth	350.00%	-	-	-	-
Total	99.99M	79.91M	-	45.52M	45.18M
Total Growth	25.13%	-	-	0.75%	9.83%

Source: S&P Global Market Intelligence.